Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Eiber

Showing results (41-50 of 376) with videos related to

Pageof 38
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 16, 2017
Comparison of <sup>68</sup>Ga-PSMA-11 and <sup>18</sup>F-Fluciclovine PET/CT in a Case Series of 10 Patients with Prostate Cancer RecurrenceJeremie Calais, Wolfgang P Fendler, Ken Herrmann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 3, 2018
Reply: Comparison of <sup>68</sup>Ga-PSMA-11 and <sup>18</sup>F-Fluciclovine PET/CT in a Case Series of 10 Patients with Prostate Cancer Recurrence: Prospective Trial Is on Its WayJeremie Calais, Wolfgang Peter Fendler, Ken Herrmann, et al.
BMC Medical Imaging|December 24, 2025
LLM-powered TNM staging of neuroendocrine tumors from PET/CT reportsMarkus Mergen, Daniel Spitzl, Matthias Eiber, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 1, 2017
Diagnosis and Treatment of Prostate Cancer: What Americans Can Learn From International OncologistsNicholas James, John Graham, Tobias Maurer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 14, 2014
PET/MR in Oncology: Non-18F-FDG Tracers for Routine ApplicationsIsabel Rauscher, Matthias Eiber, Michael Souvatzoglou, et al.
World Journal of Urology|January 27, 2018
Novel technology of molecular radio-guidance for lymph node dissection in recurrent prostate cancer by PSMA-ligandsIsabel Rauscher, Thomas Horn, Matthias Eiber, et al.
Zeitschrift Fur Medizinische Physik|February 22, 2023
Population-based model selection for an accurate estimation of time-integrated activity using non-linear mixed-effects modellingDeni Hardiansyah, Ade Riana, Matthias Eiber, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 14, 2022
Lymph node classification in E‑PSMA reporting guidelines for PSMA‑PETDaniela E Oprea-Lager, Francesco Ceci, Matthias Eiber, et al.
Nuklearmedizin. Nuclear Medicine|November 2, 2020
An in silico study on the effect of the radionuclide half-life on PET/CT imaging with PSMA-targeting radioligandsNusrat Jihan Begum, Gerhard Glatting, Matthias Eiber, et al.
The Lancet. Oncology|July 6, 2010
Radionuclide and hybrid imaging of recurrent prostate cancerAmbros J Beer, Matthias Eiber, Michael Souvatzoglou, et al.
Pageof 38

Showing results (41-50 of 376) with videos related to

Sort By:
Pageof 38
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 16, 2017
Comparison of <sup>68</sup>Ga-PSMA-11 and <sup>18</sup>F-Fluciclovine PET/CT in a Case Series of 10 Patients with Prostate Cancer RecurrenceJeremie Calais, Wolfgang P Fendler, Ken Herrmann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 3, 2018
Reply: Comparison of <sup>68</sup>Ga-PSMA-11 and <sup>18</sup>F-Fluciclovine PET/CT in a Case Series of 10 Patients with Prostate Cancer Recurrence: Prospective Trial Is on Its WayJeremie Calais, Wolfgang Peter Fendler, Ken Herrmann, et al.
BMC Medical Imaging|December 24, 2025
LLM-powered TNM staging of neuroendocrine tumors from PET/CT reportsMarkus Mergen, Daniel Spitzl, Matthias Eiber, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 1, 2017
Diagnosis and Treatment of Prostate Cancer: What Americans Can Learn From International OncologistsNicholas James, John Graham, Tobias Maurer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 14, 2014
PET/MR in Oncology: Non-18F-FDG Tracers for Routine ApplicationsIsabel Rauscher, Matthias Eiber, Michael Souvatzoglou, et al.
World Journal of Urology|January 27, 2018
Novel technology of molecular radio-guidance for lymph node dissection in recurrent prostate cancer by PSMA-ligandsIsabel Rauscher, Thomas Horn, Matthias Eiber, et al.
Zeitschrift Fur Medizinische Physik|February 22, 2023
Population-based model selection for an accurate estimation of time-integrated activity using non-linear mixed-effects modellingDeni Hardiansyah, Ade Riana, Matthias Eiber, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 14, 2022
Lymph node classification in E‑PSMA reporting guidelines for PSMA‑PETDaniela E Oprea-Lager, Francesco Ceci, Matthias Eiber, et al.
Nuklearmedizin. Nuclear Medicine|November 2, 2020
An in silico study on the effect of the radionuclide half-life on PET/CT imaging with PSMA-targeting radioligandsNusrat Jihan Begum, Gerhard Glatting, Matthias Eiber, et al.
The Lancet. Oncology|July 6, 2010
Radionuclide and hybrid imaging of recurrent prostate cancerAmbros J Beer, Matthias Eiber, Michael Souvatzoglou, et al.
Pageof 38